30 closest matches · ranked by relevance
Cancer Diagnosis · Diagnostic Techniques and Procedures · Diagnostic Imaging
Primary: Absolute Accuracy of SUV Max of PET/CT vs PET/MRI — 1.78; 1.08; 0.54; 0.51 ratio
Cardiac Disease · Dementia · Inflammatory Disease
Primary: Overall Image Quality Scores
Breast Cancer · Unspecified Adult Solid Tumor, Protocol Specific
Primary: Attenuation Correction for PET/MRI, Assessed Using Standard Uptake Values (SUVs) (Cohorts I & II)
Cancer Disease Progression
Primary: Inter-observer (B1 and B2) Reproducibility of the PET-CT by Anatomical Regions — 0.7254; 0.7854; 0.7597; 0.6711 Weighted kappa concordance coefficient
Any Condition With a Clinical Indication for PET/CT Exam
Primary: PET/MR Images Clinical Usefulness — 51 Participants
Neuroendocrine Tumors · Prostate Cancer
Primary: Completion of Two PET/CT Scans Per Patient as Dictated by Assigned Arm — 30; 30; 40 PET/CT scans
Cancer
Primary: Cohort 1 - NaF PET/CT vs 99mTc-MDP Bone Scintigraphy — 10; 0; 0 Participants
Subjects With Clinical Indication for PET/CT
Primary: Number Usable PET/MRI Image Sets — 70 Usable image sets
Lung Carcinoma · Solitary Pulmonary Nodule · Cigarette Smoking Behavior
Primary: Ability of 18F-FSPG PET/CT to Discriminate Benign From Malignant Nodules — 0.706; 0.778; 0.731; 0.817 proportion, range 0 to 1, higher better
Adult Hepatocellular Carcinoma · Localized Resectable Adult Liver Carcinoma
Primary: Fluorine-18 (18F) Fluoromethylcholine (FCH) PET/CT Parameters for Assessing Hepatocellular Carcinoma (HCC): Area Under the Receiver Operating Characteristic Curve…
Coronary Artery Disease
Primary: Safety and Tolerability of Combined Exercise and Regadenoson Stress — 0; 3; 3; 0 Participants
Cancer
Primary: Diagnostic Image Quality — 4.96; 4.30 score on a scale — p=<0.0000001
Prostate Cancer
Primary: Compare the Biodistribution of 11C-acetate Positron Emission Tomography (PET)/Computed Tomography (CT) Imaging in Tumor and Non Tumorous Regions of the Prostate — 4.4…
High-grade Glioma · Lung Cancer · Head & Neck Cancer
Primary: Correlation of the Magnitude of [18F]Fluciclatide Uptake and Retention With Quantitative Measurement of the Levels of αvβ3 (Beta-3 Integrin) Integrin Expression in…
Glioblastoma Multiforme · Brain Metastases
Primary: Tumor to Background Ratios (TBR) Post-imaging for All Lesions With PET Uptake — 8.25; 8.75 Ratio of PET SUV
Childhood Cancer
Primary: Diagnostic Accuracy of PET/MRI
Castration-Resistant Prostate Carcinoma · Metastatic Prostate Carcinoma · Stage IVB Prostate Cancer AJCC v8
Primary: Patients Reporting Adverse Reactions — 0 Participants
Cholecystitis
Primary: Sensitivity and Specificity of FDG PET/CT and Tc99mHIDA in the Evaluation of Subjects Suspected of Cholecystitis — 9; 0; 1; 1 Participants
Brain Imaging · Whole Body Imaging
Primary: Diagnostic Image Quality — 4.4; 3.9 scores on a scale
Coronary Artery Disease
Primary: Number of Flow-limiting Coronary Artery Stenosis on CT — 8 Coronary arteries
Pancreatic Cancer · Pancreatitis · IPMN
Primary: SUVmax (Maximal Standard Uptake Value) Measurement 30 and 90 Min p.i. (Post Injection) — 0.77; 0.78; 0.81; 0.8 SUVmax — p=0.78
Metastatic Prostate Cancer
Primary: Evidence of Metastatic Prostate Cancer — 0; 36; 0; 10 Participants
Arrhythmias, Cardiac
Primary: Device Malfunction — 24; 52 Participants
Ischemic Heart Disease
Primary: Diagnostic Accuracy of Cardiac PET/MRI Examination — 50; 64; 61; 64 percentage — p=0.35
Prostate Carcinoma Metastatic to the Bone · Castration Resistant Prostate Cancer
Primary: Percentage of Participants With at Least (>=) 1 Responding Bone Lesion Assessed by Total Sodium Fluoride (NaF) Standardized Uptake Value [SUVtotal] at Third 18F-NaF…
Lung Cancer · Head and Neck Cancer
Primary: [F-18]FLT PET Scan for Early Assessment of Tumor Response to Radiation or Chemoradiotherapy Compared to [F-18] FDG PET Scan
Lung Cancer, Nonsmall Cell
Primary: Data on Whole-body Pharmacokinetics of [18F]F-AraG Physiologic Uptake in Various Healthy Tissues — 0.31; 4.36; 0.04; 32.88 SUV
Liver Tumor · Liver Neoplasms
Primary: Number and Percentage of Tumors With Complete, Circumferential Ablation Margin Visibility During FDG PET/CT-guided Liver Ablations (AP-PET-1 v. Contrast-enhanced MRI)…
Uterine Cervical Neoplasms · Endometrial Neoplasms · Anus Neoplasms
Primary: Percent Difference From Baseline IMRT Plan (%) — -4.7; -9.3; -14.2; -13.4 Percent difference (%)
Prostatic Neoplasms · Prostate Cancer · Recurrence
Primary: Region-level Correct Localization Rate (CLR) of Vidoflufolastat (18F) — 75.0; 68.9; 65.2 Percentage of regions